**Correction to**: *British Journal of Cancer* (2003) **88**, 1025--1031. doi: 10.1038/sj.bjc.6600831

The authors have recently notified us of an error in the above paper. It had come to their attention that, due to a coding error, a number of patients who received chemotherapy or radiotherapy were misclassified as having no treatment. The proportions of patients receiving any chemotherapy, radiotherapy and any active treatment were too low as reported. The median percentage and range of patients receiving different treatments within the health authorities are shown below in the revised [Table 3](#tbl1){ref-type="table"} Table 3(revised) Median percentage and range of lung cancer patients with each treatment by health authority, 1995--1999 **Med %Range**None registered^a^3832--55Chemotherapy only (Chem)106--17Radiotherapy only (RT)3225--44Non-investigative surgery only (S)64--10Chem+RT95--14S+Chem00--1S+RT10--3S+Chem+RT00--1   Investigative surgery only2015--40   Any Chem2014--29Any RT4231--54Any S75--12Any treatment^b^6245--68   First hospital visited a radiotherapy centre278--79[^1][^2].

In the revised analyses, there was still evidence of health authority level variation in treatment and survival similar to that shown in Figure 1. The associations of area and health service characteristics are shown in the revised [Table 5](#tbl2){ref-type="table"} Table 5(revised) Area and organisational characteristics associated with treatment and survival **OR95% CI*P*-value***Any treatment* First hospital visited a radiotherapy centre1.841.46--2.32\<0.0001 Deprivation (Townsend score)0.980.96--0.990.0091 Age standardised incidence (per 100 000)1.000.99--1.010.9128    *Any chemotherapy* First hospital visited a radiotherapy centre1.240.98--1.550.0699 Deprivation (Townsend score)0.960.94--0.980.0001 Age standardised incidence (per 100 000)1.021.01--1030.0018    *Any radiotherapy* First hospital visited a radiotherapy centre1.671.32--2.10\<0.0001 Deprivation (Townsend score)1.000.99--1.020.7759 Age standardised incidence (per 100 000)1.000.99--1.010.9748    *Any non-investigate surgery* First hospital visited a radiotherapy centre1.020.63--1.640.9383 Deprivation (Townsend score)0.980.95--1.010.1206 Age standardised incidence (per 100 000)0.970.96--0.990.0005    *1-year survival*^a^ First hospital visited a radiotherapy centre1.180.96--1.450.1146 Deprivation (Townsend score)1.011.00--1.030.0827 Age standardised incidence (per 100 000)0.990.98--1.000.0208    *3-year survival*^a^ First hospital visited a radiotherapy centre1.190.99--1.430.0674 Deprivation (Townsend score)1.011.00--1.030.1320 Age standardised incidence (per 100 000)0.990.98--1.000.0276[^3][^4]. There were no material changes in the associations of survival with all area and health service characteristics. In the analysis of determinants of chemotherapy, radiotherapy and any treatment, the associations of treatment with the lung cancer incidence rates were sensitive to correction of the error.

The main conclusion of the paper that there is significant geographical variation in the treatment of lung cancer, which may be associated with differential access to oncology services, is still supported.

[^1]: Includes patients who had investigative surgery only.

[^2]: Any treatment=any chemomerapy, radiotherapy or non-investigative surgery.

[^3]: Odds ratios adjusted for sex, age group, histology and stage of tumour, deprivation, lung cancer incidence, whether first hospital attended was a radiotherapy centre and hospital fitted as random effect.

[^4]: Also adjusted for active treatment.
